Jyothy Labs Q3 Results: Revenue up 5% on broad-based volume growth; profit, margin soften

1 hour ago

HomeMarket NewsJyothy Labs Q3 Results: Revenue up 5% on broad-based volume growth; profit, margin soften

Jyothy Labs posted steady volume-led revenue growth in Q3, though higher costs and pricing actions weighed on profitability, even as modern trade and quick commerce remained strong.

2 Min Read

Jyothy Labs Ltd reported a mixed performance for the December quarter, with revenue growth supported by healthy volume expansion across categories, even as profitability and margins moderated year-on-year.


Net profit declined 7.3% to ₹81 crore in Q3, compared with ₹87.4 crore a year earlier. Revenue rose 5% year-on-year to ₹740 crore from ₹704 crore, driven by broad-based volume growth across segments.


EBITDA fell 4.4% to ₹111 crore, while EBITDA margin slipped to 15% from 16.5% in the year-ago period.


Post the earnings announcement, shares of Jyothy Labs were trading 0.45% higher at ₹245.28 on the NSE as of 1:35 pm, after touching an intraday low of ₹241.50.


The company said volume growth remained broad-based across categories. General Trade showed early signs of revival, while Modern Trade, E-commerce and Quick Commerce continued to post double-digit growth. Fabric Care, Personal Care and Household Insecticides delivered strong performances during the quarter. Dishwash volumes grew, though value remained under pressure due to price cuts and grammage-led promotions.


Fabric Care reported a 9.2% value growth, led by strong volume traction. Liquid detergents across brands such as Ujala, Henko, Mr White and Morelight performed well, aided by the new ‘Dr Wool’ launch. Detergent powders remained stable, though pricing in liquid detergents continued to stay competitive.


The Dishwashing segment saw a 1.3% decline in value, even as volumes rose 7%, supported by pricing actions and promotions. Liquids continued to outperform bars.


Personal Care returned to growth, rising 10.9% in value and 7.7% in volume, as the post-GST disruption seen in September and October eased by the end of November.


Household Insecticides grew 12.6% in value, led by strong volume growth in liquid vaporizers. While coils declined, this was offset by growth in liquid vaporizers and newer formats. The Maxo Aerosol launch continued to scale up, supporting the medium-term turnaround plan.


Commenting on the performance, M R Jyothy, Chairperson and Managing Director, Jyothy Labs Limited, said: “Q3 marked steady progress with healthy volume growth across our portfolio. General Trade saw a welcome recovery, while modern formats like Quick Commerce continued to scale. Despite price cuts and higher input costs, we’ve managed margins through cost control and sharper execution.”


She added that the company remains focused on scaling innovation, strengthening brands and accelerating growth across segments, with an aim to enter FY27 with double-digit volume growth, subject to supportive macro conditions.

Read Full Article at Source